Literature DB >> 35994158

Bone regeneration in osteoporosis: opportunities and challenges.

Dhrumi Patel1, Sarika Wairkar2.   

Abstract

Osteoporosis is a bone disorder characterised by low bone mineral density, reduced bone strength, increased bone fragility, and impaired mineralisation of bones causing an increased risk of bone fracture. Several therapies are available for treating osteoporosis which include bisphosphonates, anti-resorptive agents, oestrogen modulators, etc. These therapies primarily focus on decreasing bone resorption and do not assist in bone regeneration or offering permanent curative solutions. Additionally, these therapies are associated with severe adverse events like thromboembolism, increased risk of stroke, and hypocalcaemia. To overcome these limitations, bone regenerative pathways and approaches are now considered to manage osteoporosis. The bone regenerative pathways involved in bone regeneration include wingless-related integration site/β-catenin signalling pathway, notch signalling pathway, calcium signalling, etc. The various regenerative approaches which possess potential to heal and replace the bone defect site include scaffolds, cements, cell therapy, and other alternative medicines. The review focuses on describing the challenges and opportunities in bone regeneration for osteoporosis.
© 2022. Controlled Release Society.

Entities:  

Keywords:  Bone regeneration; Cell therapy; Cements; Osteoporosis; Scaffolds

Year:  2022        PMID: 35994158     DOI: 10.1007/s13346-022-01222-6

Source DB:  PubMed          Journal:  Drug Deliv Transl Res        ISSN: 2190-393X            Impact factor:   5.671


  67 in total

1.  Autogenous bone: is it still the gold standard?

Authors:  Craig M Misch
Journal:  Implant Dent       Date:  2010-10       Impact factor: 2.454

Review 2.  Osteoporosis: now and the future.

Authors:  Tilman D Rachner; Sundeep Khosla; Lorenz C Hofbauer
Journal:  Lancet       Date:  2011-03-28       Impact factor: 79.321

Review 3.  Understanding and managing secondary osteoporosis.

Authors:  Luciano Colangelo; Federica Biamonte; Jessica Pepe; Cristiana Cipriani; Salvatore Minisola
Journal:  Expert Rev Endocrinol Metab       Date:  2019-02-08

4.  Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025.

Authors:  Russel Burge; Bess Dawson-Hughes; Daniel H Solomon; John B Wong; Alison King; Anna Tosteson
Journal:  J Bone Miner Res       Date:  2007-03       Impact factor: 6.741

Review 5.  An overview and management of osteoporosis.

Authors:  Tümay Sözen; Lale Özışık; Nursel Çalık Başaran
Journal:  Eur J Rheumatol       Date:  2016-12-30

6.  Osteoporosis treatment: bisphosphonates reign to continue for a few more years, at least?

Authors:  Michael Pazianas; Bo Abrahamsen
Journal:  Ann N Y Acad Sci       Date:  2016-08-15       Impact factor: 5.691

Review 7.  Strontium ranelate in osteoporosis.

Authors:  J-Y Reginster
Journal:  Curr Pharm Des       Date:  2002       Impact factor: 3.116

Review 8.  Epidemiology of osteoporotic fractures.

Authors:  Olof Johnell; John Kanis
Journal:  Osteoporos Int       Date:  2004-09-08       Impact factor: 4.507

9.  The current and future therapies of bone regeneration to repair bone defects.

Authors:  Eijiro Jimi; Shizu Hirata; Kenji Osawa; Masamichi Terashita; Chiaki Kitamura; Hidefumi Fukushima
Journal:  Int J Dent       Date:  2012-03-13

10.  Clinician's Guide to Prevention and Treatment of Osteoporosis.

Authors:  F Cosman; S J de Beur; M S LeBoff; E M Lewiecki; B Tanner; S Randall; R Lindsay
Journal:  Osteoporos Int       Date:  2014-08-15       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.